# ARM Holdings plc: financial statements, quarterly

ARM · Nasdaq · CIK 1973239 · [Technology](/sectors/technology.md) · fiscal year ends Mar 31

Pages: [Overview](/companies/arm.md) · [Financials](/companies/arm/financials.md) · [Filings](/companies/arm/filings.md) · [Insiders](/companies/arm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/arm/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2021-03-31) | period not labelled (2022-03-31) | period not labelled (2023-03-31) | FY2024 (2024-03-31) | FY2025 (2025-03-31) | FY2026 (2026-03-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | not reported | not reported | [1.6](/filings/0001973239-24-000012.md) | [1.9](/filings/0001973239-25-000016.md) | [2.1](/filings/0001973239-26-000097.md) | [2.8](/filings/0001973239-26-000097.md) |
| Current assets | $bn | not reported | not reported | [3.5](/filings/0001973239-24-000012.md) | [4.2](/filings/0001973239-25-000016.md) | [4.8](/filings/0001973239-26-000097.md) | [6.2](/filings/0001973239-26-000097.md) |
| Total assets | $bn | not reported | not reported | [6.9](/filings/0001973239-24-000012.md) | [7.9](/filings/0001973239-25-000016.md) | [8.9](/filings/0001973239-26-000097.md) | [10.7](/filings/0001973239-26-000097.md) |
| Current liabilities | $bn | not reported | not reported | [1.4](/filings/0001973239-24-000012.md) | [1.5](/filings/0001973239-25-000016.md) | [0.9](/filings/0001973239-26-000097.md) | [1.0](/filings/0001973239-26-000097.md) |
| Total liabilities | $bn | not reported | not reported | [2.8](/filings/0001973239-24-000012.md) | [2.6](/filings/0001973239-25-000016.md) | [2.1](/filings/0001973239-26-000097.md) | [2.4](/filings/0001973239-26-000097.md) |
| Shareholders' equity | $bn | [4.1](/filings/0001973239-24-000012.md) | [3.5](/filings/0001973239-25-000016.md) | [4.1](/filings/0001973239-26-000097.md) | [5.3](/filings/0001973239-26-000097.md) | [6.8](/filings/0001973239-26-000097.md) | [8.3](/filings/0001973239-26-000097.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity

Shares outstanding: 1,064,055,252 at 2026-03-31, from the cover of the [20-F filed 2026-05-26](/filings/0001973239-26-000097.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:50 ET. No prices; not investment advice.